State Of Wisconsin Investment Board Provention Bio, Inc. Transaction History

State Of Wisconsin Investment Board

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$6.7 - $24.21 $48,213 - $174,215	-7,196 Reduced 9.27%	70,466 $1.7 Million
Q4 2022 Feb 14, 2023	BUY	$4.52 - $10.57 $305,190 - $713,686	67,520 Added 665.75%	77,662 $820,000
Q3 2022 Nov 14, 2022	SELL	$3.43 - $5.62 $9,782 - $16,028	-2,852 Reduced 21.95%	10,142 $46,000
Q2 2022 Aug 15, 2022	BUY	$3.65 - $7.3 $47,428 - $94,856	12,994 New	12,994 $52,000
Q4 2021 Feb 11, 2022	SELL	$5.59 - $7.39 $375,089 - $495,869	-67,100 Closed	0 $0

Q4 2020 Feb 03, 2021	SELL	$11.79 - $18.94 $10,611 - $17,046	-900 Reduced 1.32%	67,100 $1.14 Million
Q2 2020 Aug 12, 2020	BUY	$7.81 - $17.0 $531,080 - $1.16 Million	68,000 New	68,000 $959,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.